Going in GTP cycles in the nucleolus by Misteli, Tom
T
H
E
J
O
U
R
N
A
L
O
F
C
E
L
L
B
I
O
L
O
G
Y
 
JCB: COMMENT
 
JCB 177
 
The Journal of Cell Biology, Vol. 168, No. 2, January 17, 2005 177–178
http://www.jcb.org/cgi/doi/10.1083/jcb.200412038
 
Going in GTP cycles in the nucleolus
 
Tom Misteli
 
National Cancer Institute, National Institutes of Health, Bethesda, MD 20892
 
Proteins are directed to cellular compartments by speciﬁc
localization signals. A GTP-driven cycle has now been
identiﬁed as a mechanism for protein targeting to the nucle-
olus. The involvement of a GTP switch suggests that nucle-
olar localization can be regulated and may be responsive
to extracellular stimuli via signaling pathways. The uncov-
ered mechanism also implies that localization is determined
by increased retention rather than directed targeting.
 
A hallmark of mammalian cells is the presence of cellular com-
partments containing distinct sets of resident proteins. These are
directed to their home compartment via short peptide stretches
that act as targeting signals. Mechanisms for guiding proteins
into the secretory pathway, to cytoplasmic organelles or to the
cell nucleus have been extensively characterized. The situation
is somewhat different in the nuclear interior. It has been difficult
to find strong consensus sequences that direct proteins to one of
the many subnuclear domains. Even large-scale proteomic anal-
ysis has, for example, not revealed a simple signal that targets
proteins to the nucleolus (Andersen et al., 2002; Scherl et al.,
2002). Identifying the molecular pathways for localization of
proteins to nuclear compartments is a critical task in understand-
ing nuclear function and its regulation. Tsai and McKay report
in this issue the first detailed molecular mechanism for targeting
of a protein to the nucleolus (Tsai and McKay, 2005).
Nucleolar proteins are increasingly recognized as possible
regulators of cell growth and proliferation (Olson, 2004). One
such regulator is the nucleostemin protein. Nucleostemin has
been reported to be preferentially present in embryonic and
adult stem cells of several lineages and to be abruptly down-reg-
ulated during differentiation (Tsai and McKay, 2002). The pres-
ence of nucleostemin in highly proliferative cell types led to the
suggestion that this protein contributes to regulation of growth.
In support, misexpression of nucleostemin by overexpression or
depletion has antiproliferative effects. Consistent with its possi-
ble role in proliferation, nucleostemin appears overexpressed in
at least some cancer cell lines (Tsai and McKay, 2002).
Nucleostemin accumulates in the nucleolus. Its NH
 
2
 
-ter-
minal basic domain is necessary and sufficient for this localiza-
tion. In addition, the protein contains two GTP-binding do-
mains, which prompted Tsai and McKay to ask whether these
domains contribute to protein localization. Sure enough, muta-
tions in the GTP-binding sites caused decreased binding of
GTP to nucleostemin and displaced the protein from the nucle-
olus leading to its diffuse nuclear distribution. This observation
directly shows that GTP binding is important for nucleolar
localization of nucleostemin.
But how does GTP binding lead to nucleolar accumula-
tion? A key observation to resolve this question is the fact that
nucleostemin does not statically associate with the nucleolus,
despite its steady-state enrichment in the organelle. Like many
other proteins with nucleolar residency (Chen and Huang,
2001), nucleostemin rapidly cycles between the nucleolus and
the nucleoplasm. Since GTP-binding domains often function as
molecular switches, Tsai and McKay hypothesized that GTP
binding might modulate the dynamic association of nucleo-
stemin with the nucleolus. Combinatorial deletion analysis and
photobleaching microscopy to test the binding dynamics in
vivo revealed indeed a GTP-driven localization cycle (Tsai and
McKay, 2005). This cycle centers around the action of an in-
hibitory domain that modulates in a GTP-dependent fashion
the ability of the basic localization domain to stably interact
with nucleolar components (Fig. 1). Binding of GTP allows the
basic domain to undergo long-term interactions with nucleolar
components, resulting in the accumulation of the protein in the
nucleolus. Exchange of GTP in the nucleolus then reverses this
stable binding and releases the protein into the nucleoplasm,
establishing a GTP-driven cycle. How exactly the inhibitory
domain exerts its effect, whether through steric hindrance of
the basic domain or via additional nucleoplasmic or nucleolar
protein factors, and what nucleostemin binds to in the nucleo-
lus remain to be determined. Answers to these questions will
not only reveal a great deal about the localization mechanism,
but will likely also have a critical impact on uncovering nu-
cleostemin’s role in proliferation.
An important implication from this localization mechanism
is that the steady-state localization of nucleostemin in the nucleo-
lus is not due to increased targeting, but is primarily the result of
prolonged nucleolar retention. Thus, the “targeting” signal con-
tained in the basic domain is in reality a “retention” signal whose
function is to capture the rapidly diffusing protein at a specific
spatial location. It seems likely that the principle of retention
rather than directed targeting to determine localization is not only
valid for nucleostemin, but for many proteins that accumulate in
nuclear subcompartments and other cellular locales (Dundr and
Misteli, 2002). Such use of retention of diffusing molecules as a
mechanism for localization is consistent with a suggested contri-
bution of self-organization to cellular architecture (Misteli, 2001).
Control of a protein’s function or localization by a GTP cy-
cle is generally a smoking gun for its regulation by signaling cas-
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cades. Given the dynamic nature of its localization mechanism,
changes in the nucleolar concentration of nucleostemin might
easily be achieved by either influencing the amount of available
nucleostemin that can be imported into the nucleolus or by con-
trolling the retention kinetics. In support, the authors show that
lowering intracellular GTP levels by pharmacological agents and
withdrawal of cells from the cell cycle results in a decrease in nu-
cleolar retention of nucleostemin via modulation of its dynamic
exchange properties. How sensitive nucleostemin localization is
to GTP levels and whether changes of the size observed under
physiological conditions during signaling events is sufficient to
alter the protein’s localization remains to be seen. It might be
more plausible to assume that GTP/GDP exchange factors in the
nucleoplasm and the nucleolus are responsible for transmitting
signals to nucleostemin, although the identity of the exchange
factors for nucleostemin is not known. Regardless, the potential
connections between nucleolar localization and signaling are tan-
talizing given the protein’s link to proliferation control.
The dynamic accumulation of nucleostemin is reminis-
cent to that of other regulators of proliferation and cell cycle
control. Sequestration into the nucleolus of MDM2, an E3
ubiquitin ligase that marks p53 for destruction, results in re-
duced rates of p53 degradation and has been suggested to con-
tribute to p53 regulation (Olson, 2004). Similarly, in 
 
S. cerevi-
siae
 
 the cell cycle regulator cdc14 appears to be stored in the
nucleolus until it becomes released before anaphase to initiate
a sequence of events to promote progression through late
M-phase and exit from mitosis (Azzam et al., 2004). Interestingly,
in all those cases, the site of action of these nucleolarly seques-
tered proteins is in the nucleoplasm. Extending this theme to
nucleostemin then raises the question of whether nucleostemin
exerts its functions in the nucleolus proper or whether its asso-
ciation with the nucleolus is primarily a means to regulate its
concentration in the nucleoplasm. Either scenario is plausible
and it will be important to resolve this issue, especially since
there is at present no evidence to think that nucleostemin is in-
volved in ribosome biogenesis or assembly.
The demonstration of a GTP-driven retention cycle is a
clear a precedent for how nucleolar localization can be tightly
regulated and potentially linked to signaling pathways. But
how general is control of nucleolar localization by GTP cycles?
A search of the Lamond database indicates that 
 
 
 
3% of the
over 700 known nucleolar proteins contain a GTP-binding or
closely related motif. This estimate suggests that direct control
by GTP cycles is a relevant but not a major pathway for nucle-
olar localization. On the other hand, as pointed out by Tsai and
Mckay, GTP-controlled localization of some nucleolar proteins
might indirectly affect the distribution of other proteins. The
B23 protein, for example, does not contain any obvious GTP
binding motives, but its dynamic retention is affected by alter-
ations in cellular GTP levels, suggesting that nucleolar proteins
can mutually affect their localization.
The involvement of a GTP-driven cycle in determining nu-
cleolar residency is important as it is the first true molecular
mechanism for nucleolar localization. The finding is conceptu-
ally important because of its demonstration that retention, rather
than active targeting, determines localization. Furthermore, the
results will be important in understanding the cellular role of nu-
cleostemin in proliferation. But maybe most importantly, the in-
volvement of a GTP cycle will hopefully be an inspiration to the
field to finally begin to systematically address the long overdue
question of how cellular signal transduction pathways and local-
ization to subnuclear compartments are functionally linked.
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Figure 1. Nucleolar localization by GTP-dependent retention. (Left) In the
absence of GTP binding, nucleostemin diffuses rapidly through the nucleo-
lus. (Right) Upon binding of GTP, the inhibitory action of the inhibitory do-
main (I) is relieved. As nucleostemin diffuses through the nucleolus, the ba-
sic domain (B) is able to undergo lasting interactions with nucleolar
components. Nucleostemin accumulates in the nucleolus due to its pro-
longed retention. Exchange of GTP reverses the stable binding, and nu-
cleostemin dissociates from the nucleolus. Signaling pathways may affect
the availability of the protein for nucleolar import and/or its retention.